Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06658730 | NOT YET RECRUITING | Vascular Disease

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
Sponsor:

W.L.Gore & Associates

Brief Summary:

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.

Condition or disease

Vascular Disease

Dissection

Dissection Aortic Aneurysm

Dissection of Aorta

Aneurysm Thoracic

Aneurysm Dissecting

Transection Aorta

Intramural Hematoma

Intervention/treatment

Endovascular

Study Type : OBSERVATIONAL
Estimated Enrollment : 1500 participants
Official Title : Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
Actual Study Start Date : 2025-04-01
Estimated Primary Completion Date : 2038-08
Estimated Study Completion Date : 2038-08

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
  • 2. Patient has been or is intended to be treated with an eligible registry device.\*
  • 3. Patient is age ≥ 18 years at time of informed consent signature.
  • * The intent to treat a patient with a Gore product must be made prior to soliciting for possible registry participation. If pre-procedure consent is not feasible, consent prior to the time of discharge for the index procedure is acceptable.
Exclusion Criteria
  • 1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
  • 2. Patient with exclusion criteria required by local law.
  • 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study\* within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.
  • * The term "study" does not apply to other observational registries or quality improvement projects. Collection of Registry Device performance from interventional studies may be permissible provided device application is not investigational and there are no novel requirements that alter follow-up conduct (i.e., protocol-mandated interventions).
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Location Details

NCT06658730

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

No Location Found